Sarepta Therapeutics (NASDAQ:SRPT)

China’s Coronavirus Could Prompt Buying Frenzy in These Biotech Stocks

China is facing an outbreak of the coronavirus, which may have spread to a few other countries in East Asia. Although less than 300 infections have been reported, there are ...
Read Full Story »

Why One Analyst Sees Sarepta’s Roche Deal Taking Off

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More

Stocks have continued to hit all-time highs almost day after day now, and the futures were marginally higher on Tuesday. The next two weeks are the period generally considered as ...
Read Full Story »

Why This Duchenne Muscular Dystropy Deal Could Be Huge

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares made a handy gain to start the week after it announced a licensing agreement with Roche. The deal provides Roche exclusive commercial rights to ...
Read Full Story »

Sarepta Catches a Big Break With Duchenne Muscular Dystrophy Drug

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares jumped on Friday after the firm announced that the U.S. Food and Drug Administration (FDA) has approved Vyondys 53 (golodirsen) for the treatment of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap, Wayfair and More

Stocks traded higher to all-time highs on Thursday on news that a China trade deal was very close, seemingly without any cares about impeachment, and the indexes were indicated up ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Arista, Booking, Dunkin, DuPont, GameStop, Generac, PBF Energy, Pinterest, Square, YETI and More

Stocks traded lower on Thursday for the end of the month, but markets hit an all-time high this week in anticipation that the Federal Reserve was going to deliver on ...
Read Full Story »

More Good News for LGMD Patients

Sarepta Therapeutics Inc. (NASDAQ: SRPT) shares jumped on Friday after the firm announced an update from its Limb-girdle muscular dystrophy Type 2E (LGMD2E) trial. Specifically, Sarepta announced the nine-month functional ...
Read Full Story »

Top Baird Health Care and Biotech Picks Have Massive Upside Potential

The more disruptive the market is, the more we look for companies that are not affected by the daily sturm and drang of the news cycle because they have supply ...
Read Full Story »

4 Biotechs Making Major Moves on Tuesday

Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. With the markets holding near all-time highs, these companies could move the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Bio-Rad, Dell, HP, Jumia, Nabriva, PG&E, Salesforce, Sarepta and More

Last week's worst one-day sell-off was followed by three straight days of rallies, and the losses have been effectively wiped out. Stocks were indicated to open marginally higher on Tuesday ...
Read Full Story »

Merrill Lynch’s Top Second-Half 2019 Small and Midcap Stock Picks

As the markets have raced to historic highs, it’s important to remember that the so-called FAANG stocks, (Facebook, Apple, Amazon, Netflix and Google) have driven much of the record-breaking performance ...
Read Full Story »

Credit Suisse Best Ideas List Still Has 50% Implied Upside for 8 Stocks

With the three major stock indexes trading at or near all-time highs, many investors are scratching their heads about where to look for new investment ideas at a time when ...
Read Full Story »

Pfizer’s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King

Pfizer Inc. (NYSE: PFE) has released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy (DMD). While these results did not necessarily live up to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Carnival, Caterpillar, Darden Restaurants, Fiserv, KeyCorp, Micron, Phillips 66 and More

The market opened lower this morning after posting an intraday all-time high for the S&P 500 yesterday. Concerns over Iran after allegedly shooting down a U.S. Air Force drone and ...
Read Full Story »